Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: Cooperative roles for CADM1, stem cell factor, and IL-6

Journal of Immunology

Volumn 181, Issue 4, 2008, Pages 2772-2780

  Hollins, Fay ^a   Kaur, Davinder ^a   Yang, Weidong ^a   Cruse, Glenn ^a   Saunders, Ruth ^a   Sutcliffe, Amanda ^a   Berger, Patrick ^a,c   Ito, Akihiko ^b   Brightling, Christopher E ^a   Bradding, Peter ^a,d  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; INTERLEUKIN 6; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; CADM1 PROTEIN, HUMAN; IMMUNOGLOBULIN; MEMBRANE PROTEIN; TUMOR SUPPRESSOR PROTEIN;

AIRWAY; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOOTH MUSCLE; CELL COMMUNICATION; CELL CULTURE; CELL MOTION; COCULTURE; CYTOLOGY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA;

CELL ADHESION; CELL COMMUNICATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-6; MAST CELLS; MEMBRANE PROTEINS; MUSCLE, SMOOTH; RESPIRATORY MUCOSA; STEM CELL FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 53149123285     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.4.2772     Document Type: Article

References (42)

1. Asher, M. I., S. Montefort, B. Bjorksten, C. K. Lai, D. P. Strachan, S. K. Weiland, and H. Williams. 2006. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 368: 733-743.
2. Masoli, M., D. Fabian, S. Holt, and R. Beasley. 2004. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59: 469-478.
3. Wardlaw, A. J., C. E. Brightling, R. Green, G. Woltmann, P. Bradding, and I. D. Pavord. 2002. New insights into the relationship between airway inflammation and asthma. Clin. Sci. 103: 201-211.
4. Cruse, G., D. Kaur, W. Yang, S. M. Duffy, C. E. Brightling, and P. Bradding. 2005. Activation of human lung mast cells by monomeric immunoglobulin E. Eur. Respir. J. 25: 858-863.
5. Bradding, P., A. F. Walls, and S. T. Holgate. 2006. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 117: 1277-1284.
6. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10: 471-480.
7. Carroll, N. G., S. Mutavdzic, and A. L. James. 2002. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 57: 677-682.
8. Carroll, N. G., S. Mutavdzic, and A. L. James. 2002. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur. Respir. J. 19: 879-885.
9. Brightling, C. E., P. Bradding, F. A. Symon, S. T. Holgate, A. J. Wardlaw, and I. D. Pavord. 2002. Mast cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346: 1699-1705.
10. Berger, P., P. O. Girodet, H. Begueret, O. Ousova, D. W. Perng, R. Marthan, A. F. Walls, and J. M. Tunon de Lara. 2003. Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEB J. 17: 2139-2141.
11. Amin, K., C. Janson, G. Boman, and P. Venge. 2005. The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma. Allergy 60: 1241-1247.
12. El-Shazly, A., P. Berger, P. O. Girodet, O. Ousova, M. Fayon, J. M. Vernejoux, R. Marthan, and J. M. Tunon-de-Lara. 2006. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J. Immunol. 176: 1860-1868.
13. Berry, M. A., A. Morgan, D. E. Shaw, D. Parker, R. H. Green, C. E. Brightling, P. Bradding, A. J. Wardlaw, and I. D. Pavord. 2007. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 62: 1043-1049.
14. Begueret, H., P. Berger, J. M. Vernejoux, L. Dubuisson, R. Marthan, and J. M. Tunon-De-Lara. 2007. Inflammation of bronchial smooth muscle in allergic asthma. Thorax 62: 8-15.
15. Brightling, C. E., R. Ward, K. L. Goh, A. J. Wardlaw, and I. D. Pavord. 1999. Eosinophilic bronchitis is an important cause of chronic cough. Am. J. Respir. Crit. Care Med. 160: 406-410.
16. Brightling, C. E., R. Ward, G. Woltmann, P. Bradding, J. R. Sheller, R. Dworski, and I. D. Pavord. 2000. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am. J. Respir. Crit. Care Med. 162: 878-882.
17. Brightling, C. E., F. A. Symon, S. S. Birring, P. Bradding, A. J. Wardlaw, and I. D. Pavord. 2003. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 58: 528-532.
18. Brightling, C. E., F. A. Symon, S. S. Birring, P. Bradding, I. D. Pavord, and A. J. Wardlaw. 2002. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J. Allergy Clin. Immunol. 110: 899-905.
19. Yang, W., D. Kaur, Y. Okayama, A. Ito, A. J. Wardlaw, C. E. Brightling, and P. Bradding. 2006. Human lung mast cells adhere to human airway smooth muscle, in part, via tumor suppressor in lung cancer-1. J. Immunol. 176: 1238-1243.
20. Brightling, C. E., A. J. Ammit, D. Kaur, J. L. Black, A. J. Wardlaw, J. M. Hughes, and P. Bradding. 2005. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am. J. Respir. Crit. Care Med. 171: 1103-1108.
21. + channels are required for human lung mast cell migration. Thorax 61: 880-885.
22. Duffy, S. M., W. J. Lawley, D. Kaur, W. Yang, and P. Bradding. 2003. Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation. J. Allergy Clin. Immunol. 112: 970-977.
23. Kassel, O., F. Schmidlin, C. Duvernelle, B. Gasser, G. Massard, and N. Frossard. 1999. Human bronchial smooth muscle cells in culture produce stem cell factor. Eur. Respir. J. 13: 951-954.
24. Elias, J. A., Y. Wu, T. Zheng, and R. Panettieri. 1997. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am. J. Physiol. 273: L648-L655.
25. Furuno, T., A. Ito, Y. Koma, K. Watabe, H. Yokozaki, J. Bienenstock, M. Nakanishi, and Y. Kitamura. 2005. The SgIGSF/SynCAM mast cell adhesion molecule promotes interaction with nerves. J. Immunol. 174: 6934-6942.
26. Sanmugalingam, D., A. J. Wardlaw, and P. Bradding. 2000. Adhesion of human lung mast cells to bronchial epithelium: evidence for a novel carbohydrate-mediated mechanism. J. Leukocyte Biol. 68: 38-46.
27. Demo, S. D., E. Masuda, A. B. Rossi, B. T. Throndset, A. L. Gerard, E. H. Chan, R. J. Armstrong, B. P. Fox, J. B. Lorens, D. G. Payan, et al. 1999. Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. Cytometry 36: 340-348.
28. Valent, P., E. Spanblochl, W. R. Sperr, C. Sillaber, K. M. Zsebo, H. Agis, H. Strobl, K. Geissler, P. Bettelheim, and K. Lechner. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80: 2237-2245.
29. Irani, A. M., G. Nilsson, U. Miettinen, S. S. Craig, L. K. Ashman, T. Ishizaka, K. M. Zsebo, and L. B. Schwartz. 1992. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80: 3009-3021.
30. Yanagida, M., H. Fukamachi, K. Ohgami, T. Kuwaki, H. Ishii, H. Uzumaki, K. Amano, T. Tokiwa, H. Mitsui, H. Saito, et al. 1995. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86: 3705-3714.
31. Igarashi, Y., M. Kurosawa, O. Ishikawa, Y. Miyachi, H. Saito, M. Ebisawa, Y. Iikura, M. Yanagida, H. Uzumaki, and T. Nakahata. 1996. Characteristics of histamine release from cultured human mast cells. Clin. Exp. Allergy 26: 597-602.
32. Oskeritzian, C. A., W. Zhao, A. L. Pozez, N. M. Cohen, M. Grimes, and L. B. Schwartz. 2004. Neutralizing endogenous IL-6 renders mast cells of the MCT type from lung, but not the MCTC type from skin and lung, susceptible to human recombinant IL-4-induced apoptosis. J. Immunol. 172: 593-600.
33. Flanagan, J. G., D. C. Chan, and P. Leder. 1991. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64: 1025-1035.
34. Ito, A., T. Jippo, T. Wakayama, E. Morii, Y. Koma, H. Onda, H. Nojima, S. Iseki, and Y. Kitamura. 2003. SgIGSF: a new mast-cell adhesion molecule used for attachment to fibroblasts and transcriptionally regulated by MITF. Blood 101: 2601-2608.
35. Koma, Y., A. Ito, K. Watabe, T. Hirata, M. Mizuki, H. Yokozaki, T. Kitamura, Y. Kanakura, and Y. Kitamura. 2005. Distinct role for c-kit receptor tyrosine kinase and SgIGSF adhesion molecule in attachment of mast cells to fibroblasts. Lab. Invest. 85: 426-435.
36. Shingai, T., W. Ikeda, S. Kakunaga, K. Morimoto, K. Takekuni, S. Itoh, K. Satoh, M. Takeuchi, T. Imai, M. Monden, and Y. Takai. 2003. Implications of nectinlike molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells. J. Biol. Chem. 278: 35421-35427.
37. Cruse, G., S. Cockerill, and P. Bradding. 2008. IgE alone promotes human lung mast cell survival through the autocrine production of IL-6. BMC Immunol. 9: 2.
38. Sellge, G., A. Lorentz, T. Gebhardt, F. Levi-Schaffer, H. Bektas, M. P. Manns, D. Schuppan, and S. C. Bischoff. 2004. Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor. J. Immunol. 172: 260-267.
39. Mierke, C. T., M. Ballmaier, U. Werner, M. P. Manns, K. Welte, and S. C. Bischoff. 2000. Human endothelial cells regulate survival and proliferation of human mast cells. J. Exp. Med. 192: 801-811.
40. Hsieh, F. H., P. Sharma, A. Gibbons, T. Goggans, S. C. Erzurum, and S. J. Haque. 2005. Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells. Proc. Natl. Acad. Sci. USA 102: 14380-14385.
41. Djukanovic, R., S. J. Wilson, M. Kraft, N. N. Jarjour, M. Steel, K. F. Chung, W. Bao, A. Fowler-Taylor, J. Matthews, W. W. Busse, et al. 2004. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am. J. Respir. Crit. Care Med. 170: 583-593.
42. Yang, W., A. J. Wardlaw, and P. Bradding. 2006. Attenuation of human lung mast cell degranulation by bronchial epithelium. Allergy 61: 569-575.